Lilly Alzheimer's Drug - Search Videos

Eli Lilly's Alzheimer's drug slowed cognitive decline in phase 3 study

Eli Lilly's Alzheimer's drug slowed cognitive decline in phase 3 study

Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's Alzheimer's treatment donanemab, which slowed disease progression in the phase 3 trial.

CNBCMay 3, 2023

Eli Lilly and Company Eli Lilly Drugs List

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly is the best stock in pharma: Trader

Eli Lilly is the best stock in pharma: Trader

CNBCMelissa Lee

Full interview with Eli Lilly CEO David Ricks on emergency use authorization of Covid-19 antibody treatment

Full interview with Eli Lilly CEO David Ricks on emergency use authorization of Covid-19 antibody treatment

Top videos

FDA advisers say Eli Lilly Alzheimer's treatment is effective

FDA advisers say Eli Lilly Alzheimer's treatment is effective

Lilly Alzheimer's drug fails in big study

Lilly Alzheimer's drug fails in big study

YahooReuters Videos

FDA Approves Eli Lilly Alzheimer's Drug

FDA Approves Eli Lilly Alzheimer's Drug

Facebookcheddar news

227 views7 months ago

Eli Lilly and Company Eli Lilly Stock Analysis

Jim Cramer: Eli Lilly stock represents real value

Jim Cramer: Eli Lilly stock represents real value

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly CEO on the company's Q2 earnings and core business performance

Eli Lilly CEO on the company's Q2 earnings and core business performance